https://www.livemint.com/market/stock-market-news/lupin-q4-results-firm-reports-consolidated-pat-of-rs-247-cr-declared-dividend-11683601961525.html
Lupin Q4FY23 results: The drug maker has reported a drop of more than 25% sequentially in consolidated PAT which is attributable to owners in March 2023 quarter. However, Q4 PAT was better on year-on-year basis on the back of strong EBITDA growth and higher r…
Create an account or login to join the discussion